01 Growing Adoption of AI-Enabled and Smart Assistive Technologies The dementia care products market is experiencing a notable shift toward smart and AI-powered assistive technologies that improve patient safety, cognitive support, and independent living. Growing demand for wearable monitoring devices, GPS trackers, smart medication dispensers, digital memory aids, and remote monitoring systems is encouraging manufacturers to develop innovative solutions that simplify daily care while reducing the burden on caregivers. The increasing preference for home-based dementia care is further accelerating the adoption of these advanced products. In March 2026, CrossSense won the £1 million Longitude Prize on Dementia for its AI-powered smart glasses featuring the virtual assistant Wispy, which helps individuals with early-stage dementia recognize objects, complete everyday tasks, and live independently for longer.
01 Increasing Prevalence of Dementia and Alzheimer's Disease The global market for dementia care products is experiencing significant growth, driven primarily by the rising incidence of dementia and Alzheimer's disease. According to the World Health Organization, approximately 55 million people worldwide will be living with dementia in 2023, with projections indicating this number will rise to 57 million by 2024. This increase is primarily due to the aging global population, which correlates with a higher prevalence of cognitive disorders. For instance, Japan, with one of the world’s oldest populations, has seen a corresponding increase in dementia cases, thereby boosting the demand for dementia care products.Additionally, dementia care products are crucial in supporting individuals with dementia, enhancing their daily living experiences, and alleviating the burden on caregivers.
01 Limitation of Product Accessibility and Affordability in Remote Areas A significant obstacle in the dementia care products industry is the restricted availability and affordability in remote and underdeveloped regions, particularly in low and middle-income countries. These areas often struggle with poorly developed distribution networks and financial constraints, making it challenging to access essential dementia care products. For example, in many parts of Sub-Saharan Africa and rural South Asia, limited healthcare infrastructure and economic hardships prevent many families from obtaining necessary care products.Moreover, the stringent clinical trial and medication development criteria in the dementia therapeutics and diagnostics market contribute to higher costs and longer development cycles. This regulatory environment hinders the timely introduction of innovative products, further limiting market expansion.
01 Ongoing Trend of An Aging Population Globally As the number of elderly individuals increases, so does the demand for products that enhance the well-being of those living with dementia. For instance, the National Institute on Aging in the US increased its funding for dementia research by 12% in 2024, reaching USD 3.5 billion. This increased funding highlights the growing focus on developing solutions for dementia care.Manufacturers have a significant opportunity to innovate and introduce products that address the unique challenges faced by people with dementia. These products should enhance safety, improve quality of life, and aid daily functioning. Companies can strategically position themselves to meet the rising demand by expanding their product portfolios to include specialized items such as GPS trackers for safety, adaptive clothing, and interactive cognitive exercises. For example, Philips’ introduction of its 'Dementia Suite' offers a comprehensive set of tools to improve patient care and caregiver support.
01 Lack of Early Diagnosis and Timely Intervention One of the major challenges facing the Dementia Care Products Market is the delayed diagnosis of dementia, particularly in low- and middle-income countries where awareness and access to specialized healthcare remain limited. Many patients are diagnosed only after the disease has progressed significantly, reducing the effectiveness of care interventions and assistive products. In addition, social stigma, inadequate caregiver education, and limited access to memory clinics further hinder early adoption of dementia care solutions, ultimately restricting market growth and affecting patient quality of life.
May 2026 Philips Healthcare expanded its connected care ecosystem by integrating advanced patient monitoring and remote care capabilities with solutions supporting elderly and dementia care. The initiative strengthens home-based care by enabling caregivers and healthcare providers to monitor vulnerable patients more effectively through connected health technologies.
February 2026 Brain+ A/S expanded the deployment of its Ayla digital cognitive therapy platform through new collaborations with dementia care providers in Europe. The expansion increases access to evidence-based cognitive stimulation tools designed to support individuals with mild-to-moderate dementia while reducing caregiver burden.
December 2025 Wonderful Platform announced the U.S. launch of Avadin™, an AI-powered Physical Care Operating System developed for senior and dementia care. The platform combines AI-driven care coordination, safety monitoring, and cognitive support technologies to enhance personalized care for individuals living with dementia in home and institutional settings.
September 2025 Buddi Ltd. launched an upgraded Buddi Smart Connect platform featuring enhanced GPS tracking, fall detection, and caregiver communication tools for people living with dementia. The new platform improves real-time location monitoring and emergency response, supporting safer home-based dementia care.